Kimryn Rathmell, M.D., Ph.D., is the Hugh Jackson Morgan Professor and chair of Medicine at Vanderbilt University Medical Center, as well as physician-in-chief for Vanderbilt University Adult Hospital and Clinics. Dr. Rathmell earned her Ph.D. in biophysics and M.D. from Stanford University. Following the completion of her M.D., she completed an internal medicine internship at the University of Chicago before attending the University of Pennsylvania, where she completed an internal medicine residency and medical oncology fellowship. She completed postdoctoral training at the University of Pennsylvania, working with Dr. Celeste Simon. Dr. Rathmell is a Fellow of the American Society for Clinical Oncology and is an elected member of the National Academy of Medicine.
A physician-scientist, Dr. Rathmell’s work focuses on the treatment and research of complex renal cell carcinomas. Her research has resulted in over 20 years of funding from the National Institutes of Health and more than 200 articles in leading peer-reviewed journals, including The New England Journal of Medicine, Nature, and the Journal of Clinical Investigation.
She is a member of The Cancer Genome Atlas, winning the American Association for Cancer Research Team Science Award in 2021, and serves on the National Cancer Institute’s Board of Scientific Advisors and on the Scientific Board of Directors for the Forbeck Foundation. She has held leadership positions for the American Society of Clinical Oncology, the Kidney Cancer Research Foundation and the American Society for Clinical Investigation (ASCI), serving as the secretary-treasurer and later president of that organization. As a result of her contributions, Dr. Rathmell has been elected to the ASCI, the Association of American Physicians, the American Clinical and Climatological Society and the American Association for the Advancement of Science as a fellow.
